A vaccine of cancer which was repeatedly tested to cure 97 percent of blood tumours in mice will have its test on humans later this year. The vaccine is said to have low-grade lymphoma and it works on many different kinds of cancers. So, patients who receive this vaccine will not necessitate any chemotherapy.
According to researchers/scientists if the vaccine is approved, expectation of the treatment to be made available for public use would be out.
This vaccine is meant to be efficacious in low-grade lymphoma, which is said to have a negative effect on a number of white blood cells in the body.
The vaccine needs to be approved soon so that the rate of cancer development in the US will be reduced to a greater extent.
According to the senior researcher, Oncologist Ronald Levy, when the two agents were used, tumours all over the body were eliminated completely. He said: “When we use these two agents together in the mice, we saw amazing body wide effects, including the elimination of tumours all over the body of the animals”.
Oncologist Levy mentioned two agents which were used in the treatment. What are these two agents?
The first agent is a short piece of DEOXYRIBONUCLEIC ACID (DNA) called CpG oligonucleotide.
The second agent is an antibody which binds to OX40 by activating the T cells so as to combat cancer cells. T cells help to trigger immune response against pathogenic micro-organisms such as viruses, in animal bodies.
The research was carried out by using laboratory mice, implanting in them two identical tumours or transplanted with mouse lymphoma.
The results? One of the tumours was injected with the vaccine, thus causing the activation of T cells. The results got suggest that the vaccine cures different types of cancer and thus, preventing it from occurring.
With this research, our hopes are heightened- bringing about the elimination of cancer cells in the body of humans.